129 related articles for article (PubMed ID: 29287926)
1. Hemoglobin, C-reactive protein and ferritin in patients with oral carcinoma and their clinical significance - A prospective clinical study.
Blatt S; Schön H; Sagheb K; Kämmerer PW; Al-Nawas B; Schiegnitz E
J Craniomaxillofac Surg; 2018 Feb; 46(2):207-212. PubMed ID: 29287926
[TBL] [Abstract][Full Text] [Related]
2. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
[TBL] [Abstract][Full Text] [Related]
4. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
[TBL] [Abstract][Full Text] [Related]
6. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
[TBL] [Abstract][Full Text] [Related]
7. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
8. Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma.
Khanna V; Karjodkar F; Robbins S; Behl M; Arya S; Tripathi A
J Cancer Res Ther; 2017; 13(3):550-555. PubMed ID: 28862225
[TBL] [Abstract][Full Text] [Related]
9. Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.
Tai SF; Chien HT; Young CK; Tsao CK; de Pablo A; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
World J Surg Oncol; 2017 Feb; 15(1):47. PubMed ID: 28209200
[TBL] [Abstract][Full Text] [Related]
10. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
[TBL] [Abstract][Full Text] [Related]
11. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
13. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.
Grimm M; Lazariotou M
Med Oncol; 2012 Sep; 29(3):1435-47. PubMed ID: 21853343
[TBL] [Abstract][Full Text] [Related]
15. Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma.
Wang Q; Song X; Zhao Y; He Q; Shi M; Xu P; Ni S; Chen Y; Lin J; Zhang L
Future Oncol; 2019 Jul; 15(19):2277-2286. PubMed ID: 31237166
[No Abstract] [Full Text] [Related]
16. Clinical significance of preoperative serum C-reactive protein in oral squamous cell carcinoma.
Acharya S; Kale J; Hallikeri K; Anehosur V; Arnold D
Int J Oral Maxillofac Surg; 2018 Jan; 47(1):16-23. PubMed ID: 28716471
[TBL] [Abstract][Full Text] [Related]
17. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: A review of the literature.
Blatt S; Krüger M; Ziebart T; Sagheb K; Schiegnitz E; Goetze E; Al-Nawas B; Pabst AM
J Craniomaxillofac Surg; 2017 May; 45(5):722-730. PubMed ID: 28318929
[TBL] [Abstract][Full Text] [Related]
19. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation.
Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU
Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma.
Skrinjar I; Brailo V; Vidovic-Juras D; Vucicevic-Boras V; Milenovic A
Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e402-7. PubMed ID: 25858079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]